← Back to Search

Not Applicable

MHNA-001 for Irritable Bowel Syndrome

N/A
Waitlist Available
Research Sponsored by Mahana Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing Mahana™ IBS, a digital program designed to help manage Irritable Bowel Syndrome (IBS) symptoms. It targets young adults who suffer from IBS. The program uses digital tools and strategies to help users understand and control their symptoms over a few months.

Eligible Conditions
  • Irritable Bowel Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in IBS Severity Scoring System from Baseline to Week 12
Secondary study objectives
Subject's Global Assessment of Relief at Week 12

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MHNA-001Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MHNA-001
2022
N/A
~200

Find a Location

Who is running the clinical trial?

Mahana TherapeuticsLead Sponsor
1 Previous Clinical Trials
100 Total Patients Enrolled
~53 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top